Shelter Pharma Reports H1 FY27 Performance and Growth Roadmap
Shelter Pharma Ltd · Financial Result · 07 Nov 2026, 11:13 pm
Shelter Pharma Reports H1 FY27 Performance and Growth Roadmap For the half year ended 30th Sep'26, Shelter Pharma posted a 35.6% YoY revenue increase to Rs 451.3 mn, driven by balanced growth across human health (Rs 222.6 mn) and animal health (Rs 228.7 mn). EBITDA grew 17.9% YoY to Rs 73.8 mn, while PAT rose 15.4% YoY to Rs 51.9 mn with an 11.5% margin. The company reaffirmed FY27 guidance of 35–40% revenue growth and announced plans to invest Rs 120–150 mn in a second plant to achieve a Rs 2,000 mn revenue target by FY30.
Original exchange filing (PDF)
More announcements from Shelter Pharma Ltd
- Attached herewith Statement of Deviation for quarter ended 30th September, 2026 · 07 Nov 2026
- With reference to the subject matter and pursuant to the Regulation 30, 32 & 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 .... · 07 Nov 2026
- Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) .... · 07 Nov 2026
- Attached here with order updates recieved on 28.10.2026 · 30 Oct 2026
- Conversion of Warrants into Equity Shares · 16 Oct 2026
- Outcome of the Board Meeting held on Friday, October 16, 2026 for conversion of warrants into Equity Shares · 16 Oct 2026
- Attached herewith Intimation for Regularization of Ms. Vinita Gadhavi as Non Executive Independent Director of the Company. · 30 Sept 2026
- Attached herewith Voting Results along with Scrutinizer Report of Shelter Pharma Limited · 30 Sept 2026
